Search by Drug Name or NDC

    NDC 71610-0300-09 Alogliptin 25 mg/1 Details

    Alogliptin 25 mg/1

    Alogliptin is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is ALOGLIPTIN BENZOATE.

    Product Information

    NDC 71610-0300
    Product ID 71610-300_a8ff5402-3a49-4f04-9868-f8b2dff3aa99
    Associated GPIs 27550010100330
    GCN Sequence Number 070517
    GCN Sequence Number Description alogliptin benzoate TABLET 25 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 34076
    HICL Sequence Number 039968
    HICL Sequence Number Description ALOGLIPTIN BENZOATE
    Brand/Generic Generic
    Proprietary Name Alogliptin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Alogliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name ALOGLIPTIN BENZOATE
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA022271
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0300-09 (71610030009)

    NDC Package Code 71610-300-09
    Billing NDC 71610030009
    Package 9000 TABLET, FILM COATED in 1 BOTTLE (71610-300-09)
    Marketing Start Date 2019-07-03
    NDC Exclude Flag N
    Pricing Information N/A